ALLR vs GILD · P/E 0.0, rev $25.0K vs P/E 18, rev $7.80B
Allarity Therapeutics Inc (ALLR) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Allarity Therapeutics Inc (ALLR) is a biotechnology company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
Latest reported ALLR revenue for 2026-06-30 was $25.0K. Net income was -$6.2M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. ALLR currently screens at market cap $15.1M and trailing P/E 0.0.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
ALLR currently screens at market cap $15.1M and trailing P/E 0.0. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the ALLR and GILD stock pages for the full models.
Not investment advice.